Repository logo
 
Publication

Macular OCT findings in ROP patients treated with both laser and bevacizumab

2012Conference object Open access
Simple item page
dc.contributor.authorSantos, C
dc.contributor.authorAzevedo, R
dc.contributor.authorPina, S
dc.contributor.authorTeixeira, S
dc.contributor.authorMelo, A
dc.date.accessioned2012-12-11T15:52:13Z
dc.date.available2012-12-11T15:52:13Z
dc.date.issued2012
dc.description.abstractObjective: To describe macular optical coherence tomography (OCT) findings in children with history of retinopathy of prematurity (ROP) treated with both laser and bevacizumab. Methods: Clinical records and OCT (Stratus OCTTM Carl Zeiss Meditec) findings of the first 3 patients treated with both laser and bevacizumab at our hospital were reviewed. Control group were patients who only had laser treatment. One eye from each patient was randomly chosen. The main outcome measure was foveal and parafoveal retinal thickness. Results: 7 eyes of 7 patients with type 1 (stage 3+) disease were studied. All eyes were submited to laser ablation of peripheral retina. The bevacizumab group (3 patients) recieved secondary intravitreal injection (0.03mL 25mg/mL). On the bevacizumab group, at three years of age, mean parafoveal retinal thickness was 219μm, mean foveal thickness was 208μm, with mean foveal depression of 11μm. On the control group (4 patients), aged between five and six years of age, mean parafoveal retinal thickness was 256μm, mean foveal thickness was 243μm, with mean foveal depression of 13μm. The Wilcoxon rank-sum test showed no statistical difference between both groups. Conclusions: recent studies in the literature have shown a reduced foveal depression in premature infants with or whithout ROP comparing with normal full-term children. We report the same findings in this series of children treated with both laser and bevacizumab.
dc.identifier.citationWORLD CONGRESS ON RETINOPATHY OF PREMATURITY, 3, Shangai, 14-16 October 2012por
dc.identifier.urihttp://hdl.handle.net/10400.10/798
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherChinese Medical Associationpor
dc.subjectRetinopatia da prematuridadepor
dc.subjectCriançapor
dc.subjectBevacizumab
dc.subjectOptical coherence tomography
dc.subjectRetinopathy of prematurity
dc.subjectChild
dc.subjectFoveal thickness
dc.titleMacular OCT findings in ROP patients treated with both laser and bevacizumabpor
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceShangaipor
oaire.citation.titleWORLD CONGRESS ON RETINOPATHY OF PREMATURITYpor
rcaap.rightsopenAccesspor
rcaap.typeconferenceObjectpor

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Macular OCT findings in ROP patients trated with both laser and bevacizumab.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

OFT - Comunicações e Conferências